Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Pentoxifylline and Tocopherol for MRONJ
NCT06409546Completed
- Sponsor
- University of Catania
- Start
- Apr 2020
- Primary completion
- Dec 2023
- Modality
- Orthosteric Ligands, Hydrogel Systems, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Randomised, double-blind trial of pentoxifylline PKB171 gel and tocopherol in medication-related osteonecrosis of the jaw (MRONJ) (2 arms), sponsored by University of Catania. Primary endpoint: Oral Health Impact Profile Short Form at 6 months. Started Apr 2020; status: completed.
02
Drugs
pentoxifylline PKB171 geltocopherol
03
Conditions
medication-related osteonecrosis of the jaw (MRONJ)
Beyond the preview
Go deeper on NCT06409546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06409546.